1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Osteoarthritis Treatment Market
2.3. Global Osteoarthritis Treatment Market, By Drug Class, 2025 (US$ Million)
2.4. Global Osteoarthritis Treatment Market, By Anatomy, 2025 (US$ Million)
2.5. Global Osteoarthritis Treatment Market, By Route of Administration, 2025 (US$ Million)
2.6. Global Osteoarthritis Treatment Market, By Channel of Distribution, 2025 (US$ Million)
2.7. Global Osteoarthritis Treatment Market, By Mode of Purchase, 2025 (US$ Million)
2.8. Global Osteoarthritis Treatment Market, By Geography, 2025 (US$ Million)
2.9. Attractive Investment Proposition by Geography, 2025

3. Osteoarthritis Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Osteoarthritis Treatment Market Vendors
3.2. Strategies Adopted by Osteoarthritis Treatment Market Vendors

4. Osteoarthritis Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Osteoarthritis Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Analgesics
5.3.2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5.3.3. Corticosteroids
5.3.4. Hyaluronic Acid
5.3.5. Pipeline Analysis

6. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Knee
6.3.2. Hip
6.3.3. Ankle
6.3.4. Shoulder
6.3.5. Hand

7. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Parenteral
7.3.2. Oral
7.3.3. Topical

8. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy
8.3.3. Online

9. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2025 Versus 2034
9.3. Market Segmentation
9.3.1. Prescription Drugs
9.3.2. Over-the-counter Drugs (OTC)

10. North America Osteoarthritis Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.3. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
10.4. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.5. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
10.6. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
10.7. Osteoarthritis Treatment Market: By Region, 2024-2034, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.7.1.1.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
10.7.1.1.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.7.1.1.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
10.7.1.1.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.7.1.2.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
10.7.1.2.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.7.1.2.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
10.7.1.2.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.7.1.3.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
10.7.1.3.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.7.1.3.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
10.7.1.3.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)

11. UK and European Union Osteoarthritis Treatment Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.3. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.4. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.5. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.6. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
11.7. Osteoarthritis Treatment Market: By Region, 2024-2034, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.7.1.1.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.7.1.1.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.7.1.1.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.7.1.1.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.7.1.2.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.7.1.2.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.7.1.2.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.7.1.2.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.7.1.3.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.7.1.3.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.7.1.3.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.7.1.3.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.7.1.4.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.7.1.4.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.7.1.4.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.7.1.4.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
11.7.1.5. France
11.7.1.5.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.7.1.5.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.7.1.5.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.7.1.5.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.7.1.5.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.7.1.6.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
11.7.1.6.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.7.1.6.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
11.7.1.6.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)

12. Asia Pacific Osteoarthritis Treatment Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.3. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.4. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.5. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.6. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
12.7. Osteoarthritis Treatment Market: By Region, 2024-2034, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.7.1.1.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.7.1.1.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.7.1.1.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.7.1.1.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.7.1.2.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.7.1.2.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.7.1.2.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.7.1.2.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
12.7.1.3. India
12.7.1.3.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.7.1.3.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.7.1.3.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.7.1.3.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.7.1.3.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.7.1.4.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.7.1.4.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.7.1.4.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.7.1.4.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.7.1.5.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.7.1.5.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.7.1.5.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.7.1.5.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.7.1.6.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
12.7.1.6.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.7.1.6.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
12.7.1.6.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)

13. Latin America Osteoarthritis Treatment Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.3. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
13.4. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.5. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
13.6. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
13.7. Osteoarthritis Treatment Market: By Region, 2024-2034, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.7.1.1.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
13.7.1.1.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.7.1.1.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
13.7.1.1.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.7.1.2.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
13.7.1.2.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.7.1.2.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
13.7.1.2.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.7.1.3.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
13.7.1.3.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.7.1.3.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
13.7.1.3.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)

14. Middle East and Africa Osteoarthritis Treatment Market, 2024-2034, USD (Million)
14.1. Market Overview
14.2. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
14.3. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
14.4. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
14.5. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
14.6. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
14.7. Osteoarthritis Treatment Market: By Region, 2024-2034, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
14.7.1.1.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
14.7.1.1.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
14.7.1.1.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
14.7.1.1.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
14.7.1.2.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
14.7.1.2.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
14.7.1.2.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
14.7.1.2.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Osteoarthritis Treatment Market: By Drug Class, 2024-2034, USD (Million)
14.7.1.3.2. Osteoarthritis Treatment Market: By Anatomy, 2024-2034, USD (Million)
14.7.1.3.3. Osteoarthritis Treatment Market: By Route of Administration, 2024-2034, USD (Million)
14.7.1.3.4. Osteoarthritis Treatment Market: By Channel of Distribution, 2024-2034, USD (Million)
14.7.1.3.5. Osteoarthritis Treatment Market: By Mode of Purchase, 2024-2034, USD (Million)

15. Company Profile
15.1. Sanofi SA. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
15.2. GlaxoSmithKline plc
15.3. Pfizer Inc
15.4. Bayer AG.
15.5. Zimmer Biomet
15.6. Horizon Therapeutics PLC.
15.7. Johnson &Johnson.
15.8. Abbott
15.9. Eli Lilly
15.10. Anika Therapeutics, Inc.
15.11. Novartis AG
15.12. Ferring Pharmaceuticals.
15.13. Bioventus
15.14. LupinLimited.
15.15. FidiaFarmaceuticiS.p.A.
15.16. Virchow Biotech